Wednesday, February 26, 2020 4:34:55 PM
Recent TNXP News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 09:42:22 PM
- Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting • GlobeNewswire Inc. • 11/13/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 02:10:11 PM
- Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals • GlobeNewswire Inc. • 11/13/2024 02:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 10:10:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 01:05:29 PM
- Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights • GlobeNewswire Inc. • 11/12/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 10:15:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/04/2024 12:30:21 PM
- Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya • GlobeNewswire Inc. • 11/04/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2024 11:05:20 AM
- Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024 • GlobeNewswire Inc. • 11/01/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 08:30:37 PM
- Tonix Pharmaceuticals to Present at BIO-Europe® 2024 • GlobeNewswire Inc. • 10/29/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2024 09:16:22 PM
- Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference • GlobeNewswire Inc. • 10/25/2024 12:00:00 PM
- Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024 • GlobeNewswire Inc. • 10/24/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2024 12:05:14 PM
- Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA) • GlobeNewswire Inc. • 10/17/2024 12:00:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/16/2024 01:01:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2024 12:05:35 PM
- Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA) • GlobeNewswire Inc. • 10/16/2024 12:00:00 PM
- Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals • GlobeNewswire Inc. • 10/08/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 11:05:22 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM